Barclays analyst Steve Valiquette lowered the firm’s price target on Medical Properties Trust to $14 from $17 and keeps an Overweight rating on the shares post the Q4 results.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MPW:
- Medical Properties Trust Earnings Report: Did it Beat Expectations?
- Medical Properties Trust COO McLean to retire
- Medical Properties Trust sees FY23 normalized FFO $1.50-$1.65, consensus $1.74
- Medical Properties Trust reports Q4 normalized FFO 43c, consensus 43c
- Beat Inflation with these Two High Yield Stocks
